Maternal and postnatal overnutrition differentially impact appetite regulators and fuel metabolism.
Maternal obesity is increasing, and it is known that the intrauterine experience programs fetal and newborn metabolism. However, the relative contributions of pre- or postnatal factors are unknown. We hypothesized that maternal overnutrition caused by long-term maternal obesity would exert a stronger detrimental impact than postnatal overnutrition on offspring metabolic homeostasis, with additional postnatal overnutrition exaggerating these alterations. Female Sprague Dawley rats were exposed to chow or high-fat cafeteria diet for 5 wk before mating and throughout gestation and lactation. On postnatal d 1, litters were adjusted to three per litter to induce postnatal overnutrition (vs. 12 in control). Hypothalamic appetite regulators neuropeptide Y and proopiomelanocortin, glucose transporter 4, and lipid metabolic markers were measured. At postnatal d 20, male pups born of obese dams, or those overnourished postnatally, were 42% heavier than controls; combining both interventions led to 80% greater body weight. Maternal obesity increased pup adiposity and led to glucose intolerance in offspring; these were exaggerated by additional postnatal overnutrition during lactation. Maternal obesity was also linked to hyperlipidemia in offspring and reduced hypothalamic neuropeptide Y and increased proopiomelanocortin mRNA expression. Postnatal overnutrition of offspring from obese dams amplified these hypothalamic changes. Both maternal and postnatal overnutrition reduced muscle glucose transporter 4. Adipose carnitine palmitoyl-transferase-1 and adipose triglyceride lipase mRNA was up-regulated only by postnatal overnutrition. Maternal overnutrition appears to alter central appetite circuits and promotes early-onset obesity; postnatal overnutrition interacted to cause peripheral lipid and glucose metabolic disorders, supporting the critical message to reduce early-life adverse nutritional impact.
Chen
Hui
H
Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia.
Simar
David
D
Lambert
Karen
K
Mercier
Jacques
J
Morris
Margaret J
MJ
D000818:Animals; D000831:Animals, Newborn; D001069:Appetite Regulation / Q000235:genetics / Q000502:physiology*; D004036:Diet, Atherogenic; D004734:Energy Metabolism / Q000235:genetics / Q000502:physiology*; D005260:Female; D005947:Glucose / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism / Q000502:physiology; D050356:Lipid Metabolism / Q000235:genetics / Q000502:physiology; D008297:Male; D039382:Maternal Nutritional Physiological Phenomena; D009478:Neuropeptide Y / Q000235:genetics / Q000378:metabolism; D044343:Overnutrition / Q000196:embryology / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology*; D011247:Pregnancy; D011333:Pro-Opiomelanocortin / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D009478:Neuropeptide Y; D011333:Pro-Opiomelanocortin; D005947:Glucose